Navigation Links
Par Pharmaceutical Reports Third Quarter 2008 Results
Date:11/6/2008

ower sales and marketing expenses of Megace(R) ES, tempered by an increase in legal fees.

Recent Events

On October 14, 2008, Par announced a resizing of its generic unit as part of an ongoing strategic assessment of its businesses. The Company will significantly reduce its research and development (R&D) expenses by decreasing its internal R&D effort to focus on completing products currently in development and will continue to look for opportunities with external partners. In addition, the Company is trimming its current generic product portfolio and retaining only those marketed products that deliver acceptable profit to the Company. These actions will result in a workforce reduction of approximately 190 employees. Approximately 30% of the affected positions in manufacturing, R&D, and general and administrative will be eliminated by year-end 2008 and the remaining positions by the end of the first half of 2009.

In connection with these actions, the Company expects to incur pre-tax expenses in the range of approximately $28-$38 million, which is comprised of approximately $11 million for severance and other employee-related costs; approximately $17-$18 million for asset impairments resulting from facility closures and related actions; up to approximately $2 million in inventory write-offs related to the reduction of the Company's generic product portfolio; and up to approximately $7 million for other costs. The Company expects that approximately $8-$10 million of this charge will result in cash expenditures during the fourth quarter of 2008 and the first half of 2009.

Also in October, the Company repurchased senior subordinated convertible notes that were to mature on September 30, 2010 in the aggregate principal amount of $58.0 million for approximately $50 million, including accrued interest. The notes bore interest at an annual rate of 2.875%. This repurchase will result in the write-off of approximately $0.5 million of deferred financi
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 First Quarter Earnings Conference Call on Tuesday, November 11, 2008 at 8:30 a.m. EST
2. Webcast Alert: Isis Pharmaceuticals Cardiovascular Program Review
3. Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Sinemet(R) Tablets
4. Alseres Pharmaceuticals, Inc. to Present at Rodman & Renshaw 10th Annual Healthcare Conference
5. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
6. Jazz Pharmaceuticals to Present at Investor Conferences
7. Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
8. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
9. NeoStem Signs Definitive Agreement to Acquire Controlling Interest in a Leading Chinese Pharmaceutical Company
10. MiddleBrook Pharmaceuticals Retains National Account Firm VCG & Associates
11. Pacira Pharmaceuticals Leverages TalentManager(R) from Salary.Com(TM) to Integrate Compensation and Performance Management Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... 2015 , ... Leah Binder, MA, MGA, president and CEO ... healthcare, will offer the keynote address at the upcoming meeting of the ACO ... Harbor, Florida, at the Innisbrook Resort and Golf Club. For an agenda and ...
(Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... ... at Johns Hopkins University Bloomberg School of Public Health and an internationally recognized ... House Fellows program for 2015-16. Dr. Bleich, a Baltimore native and 1996 graduate ...
(Date:9/2/2015)... Yorba Linda, CA (PRWEB) , ... September 02, 2015 , ... ... in the genome by using a complex of the Cas9 nuclease with either a ... a trans-activating RNA (tracrRNA)). The ability of any given guide RNA (sgRNA or crRNA) ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... cosponsored by the Military Officers Association of America (MOAA) and Wounded Warrior ... Military: Caring For Our Own,” expert panelists will lead interactive discussions on ...
(Date:9/2/2015)... ... September 02, 2015 , ... According to an article published August 12 by ... that aims to do away with grand juries in cases meant to decide if a ... direct response to grand jury decisions in Ferguson and New York City that absolved police ...
Breaking Medicine News(10 mins):Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3Health News:Dr. Sara Bleich, Garrison Forest Graduate, Selected for 2015-16 Class of White House Fellows 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3
... reported by researchers in the Journal of Hypertension ... morbidity and improve their atherosclerotic risk profile by ... indicated that serum lipoprotein(a), a powerful predictor of ... The researchers studied 402 patients with untreated essential ...
... new effort to re-examine very old drugs that ... that drugs worked well, has landed dozens of ... now FDA stressed that the expectorant, extended-release guaifenesin, ... to the FDA formally approving sale of Adams// ...
... Preventing and Reversing Atherosclerosis in Houston, Texas, United ... intense lifestyle changes plus pharmacologic lipid treatment reduces ... greater extent than usual-care cholesterol lowering drugs. They ... performing myocardial perfusion imaging at baseline and after ...
... An Australian study published in The New England Journal ... showed diuretics were superior to ACE (angiotensin-converting enzyme) inhibitors ... Australian study included 6,083 people who were mostly white. ... took a diuretic and those who took an ACE ...
... a study published in the British Medical Journal, older people ... The researchers from Cambridge, UK, identified a group of 2,686 ... sent either one capsule of Vitamin D3 or a placebo ... to provide them with information on bone fractures// and any ...
... knees, is a form of arthritis where one or ... in in these type of joint problems is the ... fluid that moisturizes the area. This fluid is called ... humans since 1987, after the therapy was proved beneficial ...
Cached Medicine News:
(Date:9/2/2015)... Sept. 2, 2015 Advanced Wound Dressings ... Advanced dressings have steadily replaced traditional bandages ... variety of wound indications, such as trauma wounds, ... control, and physical protection become increasingly critical in ... in standard therapy. This report focuses on ...
(Date:9/2/2015)... , Sept. 2, 2015  Array BioPharma ... its Chief Executive Officer, Ron Squarer , ... Conference in Boston.  The public is welcome to ... the Array BioPharma website.Event: Wells Fargo Securities Healthcare ... September 10, 2015Time:  , 10:20 a.m. Eastern Time ...
(Date:9/2/2015)... Physicians Rx Pharmacy ("PRxP") today announced that ... President and Chief Executive Officer.  Mr. Bernstein, ... Officer for Soleo Health Specialty Infusion Services, will, as ... be responsible for leading the rapidly-growing 340B pharmacy services ... Gaston on as the President and CEO of PRxP," ...
Breaking Medicine Technology:Advanced Wound Dressings - SA Analysis and Market Forecasts 2Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2
... N.M., March 11, 2011 Qforma, an advanced analytics ... Elna Hamp to Vice President, Business Development and Joann ... business models continue to evolve with the changing healthcare ... said Al Reicheg, Chief Commercial Officer of Qforma. "Our ...
... Calif., March 11, 2011 Sonitus Medical, Inc., a ... and removable hearing prosthetic to transmit sound via the ... certification for its SoundBite Hearing System. The company has ... System Approval. This is the first European regulatory certification ...
Cached Medicine Technology:Qforma Appoints Two New Executives 2Sonitus Medical Receives European CE Mark for SoundBite™ Hearing System 2
The O.R. Special Protective Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is availa...
... added an elastic belt to help lift the ... Procedure Apron features all around protection to cover ... makes wearing and removing a breeze. ,For additional ... Belts - they reduce pressure on the vertebrae ...
The O.R. Special Protective Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is availa...
The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...
Medicine Products: